Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
boston
4
×
boston blog main
boston top stories
eli lilly
4
×
life sciences
national blog main
san francisco blog main
san francisco top stories
biotech
deals
national top stories
avapritinib
blueprint medicines
boehringer ingelheim
clinical trials
genentech
indiana blog main
indiana top stories
medullary thyroid cancer
non-small cell lung cancer
pralsetinib
roche
selpercatinib
thyroid cancer
alexion pharmaceuticals
alnylam pharmaceutials
arrowhead pharmaceuticals
biontech
cancer
cancer drugs
capmatinib
cstone pharmaceuticals
curevac
dicerna pharmaceuticals
europe blog main
europe top stories
european medicines agency
fda
fisogatinib
flatiron health
What
medicines
4
×
cancer
approval
blueprint
companies
deal
drug
fda
latest
ret
rna
abandoning
address
ago
approves
baggage
bets
bio
candidate
carries
certain
comes
currently
cut
cuts
date
designed
development
dicerna
effective
enticed
evidence
free
genetic
gets
hasn’t
interference
long
marketing
messenger
Language
unset
Current search:
medicines
×
photo
×
boston
×
" eli lilly "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines